These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 22978777)
1. Are fixed-dose combination antihypertensives suitable as first-line therapy? Kjeldsen SE; Messerli FH; Chiang CE; Meredith PA; Liu L Curr Med Res Opin; 2012 Oct; 28(10):1685-97. PubMed ID: 22978777 [TBL] [Abstract][Full Text] [Related]
2. Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients. Neutel JM Curr Med Res Opin; 2008 Aug; 24(8):2389-401. PubMed ID: 18616863 [TBL] [Abstract][Full Text] [Related]
3. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Weir MR Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185 [TBL] [Abstract][Full Text] [Related]
4. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner. Roberts ME; Epstein BJ J Cardiovasc Nurs; 2009; 24(5):380-9. PubMed ID: 19707098 [TBL] [Abstract][Full Text] [Related]
5. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension. Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521 [TBL] [Abstract][Full Text] [Related]
6. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study. Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367 [TBL] [Abstract][Full Text] [Related]
7. Fixed-dose combinations of renin-angiotensin blocking agents with calcium channel blockers or hydrochlorothiazide in the treatment of hypertension. Bramlage P Expert Opin Pharmacother; 2009 Aug; 10(11):1755-67. PubMed ID: 19538001 [TBL] [Abstract][Full Text] [Related]
8. Using fixed-dose combination therapies to achieve blood pressure goals. Chrysant SG Clin Drug Investig; 2008; 28(11):713-34. PubMed ID: 18840014 [TBL] [Abstract][Full Text] [Related]
9. Angiotensin II receptor blocker combinations: from guidelines to clinical practice. Narkiewicz K Blood Press; 2012 Apr; 21(2):73-81. PubMed ID: 21830845 [TBL] [Abstract][Full Text] [Related]
10. Management of hypertension with fixed-dose triple-combination treatments. Epstein BJ; Shah NK; Borja-Hart NL Ther Adv Cardiovasc Dis; 2013 Oct; 7(5):246-59. PubMed ID: 23945906 [TBL] [Abstract][Full Text] [Related]
11. [Hypertension combination therapy with renin-angiotensin system blockers]. Soucek M Vnitr Lek; 2009 Sep; 55(9):719-23. PubMed ID: 19785368 [TBL] [Abstract][Full Text] [Related]
12. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160). Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280 [TBL] [Abstract][Full Text] [Related]
13. The role of fixed-dose combination therapy with drugs that target the renin-angiotensin system in the hypertension paradigm. Schmieder RE Clin Exp Hypertens; 2010 Jan; 32(1):35-42. PubMed ID: 20144071 [TBL] [Abstract][Full Text] [Related]
14. Optimization of hypertension management: the role of angiotensin receptor blocker-calcium channel blocker combinations. Parati G J Cardiovasc Pharmacol; 2009 May; 53(5):352-8. PubMed ID: 19365281 [TBL] [Abstract][Full Text] [Related]
15. Targeting mechanisms of hypertensive vascular disease with dual calcium channel and renin-angiotensin system blockade. Weir MR J Hum Hypertens; 2007 Oct; 21(10):770-9. PubMed ID: 17597800 [TBL] [Abstract][Full Text] [Related]
16. Combinations of inhibitors of the renin-angiotensin system with calcium channel blockers for the treatment of hypertension: focus on perindopril/amlodipine. Mourad JJ; Le Jeune S; Pirollo A; Mourad C; Gaudouen Y; Lopez-Sublet M Curr Med Res Opin; 2010 Sep; 26(9):2263-76. PubMed ID: 20690889 [TBL] [Abstract][Full Text] [Related]
17. The therapeutic importance of home blood pressure assessment and combination antihypertensive therapy for achieving target blood pressure control: Ibaraki hypertension assessment trial. Sato A; Watanabe S; Okubo S; Toi T; Doi T; Nakano H; Tada J; Aonuma K; Hypertens Res; 2010 Dec; 33(12):1264-71. PubMed ID: 20927115 [TBL] [Abstract][Full Text] [Related]
18. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management. Petrella R; Michailidis P Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126 [TBL] [Abstract][Full Text] [Related]
19. Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension. Frampton JE; Scott LJ Am J Cardiovasc Drugs; 2009; 9(5):309-30. PubMed ID: 19791840 [TBL] [Abstract][Full Text] [Related]
20. 50 years of thiazides: should thiazide diuretics be considered third-line hypertension treatment? Brown A; Captain B Am J Ther; 2011 Nov; 18(6):e244-54. PubMed ID: 21436766 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]